Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_56231 | 7 | 0.14 | Mlig455_043876 | Neo: - Age: - |
Mlig455_043876 {REF} {Length: 577} {RNA1310_34857} {RNA815_56033} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_26074 | 4 | 0.08 | Mlig455_007443 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_007443 {REF} {Length: 3942} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=94.5]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=91.3]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=55.8]; Aspartyl protease [PF13650.8, score=23.3]; gag-polyprotein putative aspartyl protease [PF13975.8, score=22.1]} {Smed: dd_Smed_v6_1574_6_40, dd_Smed_v6_1574_6_40, [Score=180, Expect=5e-49]} {RNA1509_34968} {RNA1310_827, RNA1509_34968} {RNA1509_34968, RNA815_6876} | |
2. | MligTC455_56231 | 7 | 0.14 | Mlig455_043876 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_043876 {REF} {Length: 577} {RNA1310_34857} {RNA815_56033} | |
3. | MligTC455_02154 | 8 | 0.16 | Mlig455_000640 | Neo: Irradiation Age: Up-Down-Down |
TTC17 | 0.996 | - | - | - | - | 0.996 | - | Mlig455_000640 {REF} {Length: 3975} {TRANSSPLICED} {Pfam: Tetratricopeptide repeat [PF07719.19, score=35.8]; Tetratricopeptide repeat [PF00515.30, score=33.6]; Tetratricopeptide repeat [PF13176.8, score=29.2]; Tetratricopeptide repeat [PF13424.8, score=23.7]; TPR repeat [PF13414.8, score=21.7]} {Human: ENSG00000052841, TTC17, tetratricopeptide repeat domain 17, [RH, Score=159, Expect=5e-39]} {Mouse: ENSMUSG00000027194, Ttc17, tetratricopeptide repeat domain 17, [RH, Score=160, Expect=2e-39]} {Dmel: FBgn0029713, CG11436, [RH, Score=62.8, Expect=1e-09]} {Celegans: WBGene00020553, T19A5.1, [RH, Score=57.0, Expect=9e-08]} {Smed: dd_Smed_v6_11405_0_1, dd_Smed_v6_11405_0_1, [RH, Score=258, Expect=5e-71]} {RNA1509_10619, RNA1509_58302} {RNA1310_1270.1, RNA1509_10619, RNA1509_58302} {RNA1509_10619, RNA1509_58302, RNA815_24250} |
4. | MligTC455_13493 | 28 | 0.58 | Mlig455_020299 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_020299 {REF} {Length: 568} {RNA1310_11315} {RNA815_53929} | |
5. | MligTC455_40156 | 18 | 0.38 | Mlig455_038693 | Neo: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_038693 {REF} {Length: 2831} {RNA1509_1762} {RNA1310_2511} {RNA815_910.1} | |
6. | MligTC455_32241 | 156 | 3.24 | Mlig455_063650 | Neo: - Age: - Region-enriched R4: 3.105/0.02582 |
MGLL | 0.989 | - | - | - | - | 0.989 | - | Mlig455_063650 {REF} {Length: 1932} {Pfam: Serine aminopeptidase, S33 [PF12146.10, score=135.3]; Alpha/beta hydrolase family [PF12697.9, score=39.2]; alpha/beta hydrolase fold [PF00561.22, score=34.4]; Prolyl oligopeptidase family [PF00326.23, score=21.7]} {Human: ENSG00000074416, MGLL, monoglyceride lipase, [Score=97.4, Expect=6e-23]} {Mouse: ENSMUSG00000033174, Mgll, monoglyceride lipase, [Score=106, Expect=2e-26]} {Smed: dd_Smed_v6_6796_0_1, dd_Smed_v6_6796_0_1, [Score=91.7, Expect=2e-21]} {RNA1509_47433} {RNA1310_29208} {RNA815_26468} |
7. | MligTC455_13102 | 65 | 1.35 | Mlig455_056246 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.206/0.00027 |
NWD2 | 0.987 | - | - | - | - | 0.987 | - | Mlig455_056246 {REF} {Length: 8104} {Pfam: NACHT domain [PF05729.14, score=51.2]; AAA ATPase domain [PF13191.8, score=36.8]; Domain of unknown function (DUF4062) [PF13271.8, score=36.5]; ATPase domain predominantly from Archaea [PF01637.20, score=23.7]; AAA domain [PF13401.8, score=20.6]} {Human: ENSG00000174145, NWD2, NACHT and WD repeat domain containing 2, [Score=451, Expect=2e-130]} {Mouse: ENSMUSG00000090061, Nwd2, NACHT and WD repeat domain containing 2, [RH, Score=436, Expect=2e-125]} {Dmel: FBgn0038397, CG10185, [RH, Score=980, Expect=0.0]} {Celegans: WBGene00020254, T05C3.2, [RH, Score=925, Expect=0.0]} {Smed: dd_Smed_v6_11085_0_1, dd_Smed_v6_11085_0_1, [Score=344, Expect=9e-96]} {RNA1509_20730} {RNA1310_1147} {RNA815_11922} |
8. | MligTC455_40790 | 212 | 4.43 | Mlig455_032027 | Neo: Irradiation Age: Up-Down-Down Region-enriched R2: 2.642/0.01234 |
PDE11A | 0.987 | - | - | - | - | 0.987 | - | Mlig455_032027 {REF} {Length: 3463} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=143.6]; GAF domain [PF01590.28, score=84.0]; GAF domain [PF13185.8, score=50.1]; GAF domain [PF13492.8, score=44.7]} {Human: ENSG00000128655, PDE11A, phosphodiesterase 11A, [Score=407, Expect=3e-128]; ENSG00000138735, PDE5A, phosphodiesterase 5A, [Score=405, Expect=4e-128]} {Mouse: ENSMUSG00000075270, Pde11a, phosphodiesterase 11A, [Score=405, Expect=1e-127]; ENSMUSG00000053965, Pde5a, phosphodiesterase 5A, cGMP-specific, [Score=404, Expect=5e-128]} {Dmel: FBgn0085370, Pde11, Phosphodiesterase 11, [Score=417, Expect=1e-130]} {Celegans: WBGene00016328, pde-5, Probable 3',5'-cyclic phosphodiesterase pde-5, [Score=232, Expect=1e-65]} {Smed: dd_Smed_v6_8595_0_4, dd_Smed_v6_8595_0_4, [Score=441, Expect=6e-142]} {RNA1509_52520} {RNA1310_8630.1, RNA1509_52520} {RNA1509_52520, RNA815_26873} |
9. | MligTC455_12552 | 150 | 3.13 | Mlig455_063669 | Neo: - Age: - |
0.984 | - | - | - | - | 0.984 | - | Mlig455_063669 {REF} {Length: 690} {RNA1509_32639} {RNA1310_46019, RNA1509_32639} {RNA1509_32639, RNA815_20672} | |
10. | MligTC455_53524 | 34 | 0.7 | Mlig455_010882 | Neo: - Age: - Region-enriched R2: 5.283/0.01696 |
0.981 | - | - | - | - | 0.981 | - | Mlig455_010882 {REF} {Length: 1818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.7]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=102, Expect=9e-24]} {RNA1310_45713} {RNA815_35716} | |
11. | MligTC455_43621 | 222 | 4.63 | Mlig455_025703 | Neo: - Age: - Region-enriched R4: 4.147/0.00000 |
0.979 | - | - | - | - | 0.979 | - | Mlig455_025703 {REF} {Length: 2480} {RNA1509_50338} {RNA1310_25031} {RNA815_24211} | |
12. | MligTC455_51288 | 32 | 0.66 | Mlig455_033307 | Neo: - Age: - |
NRG2 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_033307 {REF} {Length: 1876} {TRANSSPLICED} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=62.6]; Immunoglobulin domain [PF13927.8, score=57.8]; Immunoglobulin domain [PF00047.27, score=52.9]; Immunoglobulin domain [PF13895.8, score=42.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=21.9]; Immunoglobulin V-set domain [PF07686.19, score=21.5]} {Human: ENSG00000158458, NRG2, neuregulin 2, [RH, Score=78.6, Expect=9e-15]} {Mouse: ENSMUSG00000060275, Nrg2, neuregulin 2, [Score=79.3, Expect=5e-15]} {Dmel: FBgn0003984, vn, vein, [RH, Score=79.3, Expect=3e-15]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=58.5, Expect=1e-08]} {Smed: dd_Smed_v6_16809_0_1, dd_Smed_v6_16809_0_1, [RH, Score=77.8, Expect=3e-15]} {RNA1310_26045.2} {RNA815_30218} |
13. | MligTC455_38581 | 72 | 1.49 | Mlig455_056022 | Neo: - Age: - |
SCNN1B | 0.976 | - | - | - | - | 0.976 | - | Mlig455_056022 {REF} {Length: 3168} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=200.5]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=72.8, Expect=8e-13]} {Mouse: ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=70.9, Expect=2e-12]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=77.8, Expect=7e-15]} {Smed: dd_Smed_v6_31771_0_1, dd_Smed_v6_31771_0_1, [RH, Score=103, Expect=2e-23]} {RNA1509_29577} {RNA1310_8793.1} {RNA815_14483} |
14. | MligTC455_46566 | 167 | 3.47 | Mlig455_030556 | Neo: - Age: - Region-enriched R2: 2.352/0.01128 |
0.976 | - | - | - | - | 0.976 | - | Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594} | |
15. | MligTC455_18748 | 104 | 2.17 | Mlig455_024985, Mlig455_024999 | Neo: - Age: - Region-enriched R2: 6.002/0.00016 |
GRIK4 | 0.975 | - | - | - | - | 0.975 | - | Mlig455_024985 {REF} {Length: 1514} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_47299} {RNA815_38321} Mlig455_024999 {REF} {Length: 3567} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_7578, RNA1509_35538} {RNA1509_35538, RNA815_4987} |
16. | MligTC455_37545 | 27 | 0.57 | Mlig455_018611 | Neo: - Age: Up-Down-Up |
0.974 | - | - | - | - | 0.974 | - | Mlig455_018611 {REF} {Length: 3635} {TRANSSPLICED} {RNA1310_62925} {RNA815_29891} | |
17. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 0.972 | - | - | - | - | 0.972 | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
18. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
19. | MligTC455_42650 | 33 | 0.69 | Mlig455_027379 | Neo: - Age: - |
0.969 | - | - | - | - | 0.969 | - | Mlig455_027379 {REF} {Length: 661} {RNA1310_47424} {RNA815_44231} | |
20. | MligTC455_36766 | 56 | 1.17 | Mlig455_031817 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.086/0.02148 |
0.967 | - | - | - | - | 0.967 | - | Mlig455_031817 {REF} {Length: 4913} {Pfam: Caspase domain [PF00656.24, score=24.0]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=55.8, Expect=4e-08]} {RNA1509_18240} {RNA1310_3181} {RNA815_2826} | |
21. | MligTC455_03110 | 58 | 1.2 | Mlig455_069260 | Neo: - Age: - |
GABBR2 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_069260 {REF} {Length: 6190} {TRANSSPLICED} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=150.8]; Receptor family ligand binding region [PF01094.30, score=121.6]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=259, Expect=1e-73]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=255, Expect=2e-72]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=238, Expect=4e-66]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=223, Expect=8e-62]} {Smed: dd_Smed_v6_59890_0_1, dd_Smed_v6_59890_0_1, [Score=112, Expect=1e-28]} {RNA1509_59815} {RNA1310_19655} {RNA815_19308} |
22. | MligTC455_23217 | 7 | 0.15 | Mlig455_017797 | Neo: - Age: - |
GALNT13 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_017797 {REF} {Length: 3264} {TRANSSPLICED} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=111.0]; Ricin-type beta-trefoil lectin domain [PF00652.24, score=51.9]; Glycosyltransferase like family 2 [PF10111.11, score=25.7]; N-terminal domain of galactosyltransferase [PF02709.16, score=21.5]} {Human: ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [RH, Score=593, Expect=0.0]; ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [RH, Score=590, Expect=0.0]} {Mouse: ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [RH, Score=592, Expect=0.0]; ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [RH, Score=591, Expect=0.0]} {Dmel: FBgn0031681, pgant5, polypeptide GalNAc transferase 5, [RH, Score=570, Expect=0.0]} {Celegans: WBGene00001628, gly-3, Polypeptide N-acetylgalactosaminyltransferase 3, [RH, Score=538, Expect=0.0]} {Smed: dd_Smed_v6_5368_1_1, dd_Smed_v6_5368_1_1, [RH, Score=561, Expect=0.0]} {RNA1509_11621, RNA1509_52636} {RNA1310_13667.1, RNA1509_11621, RNA1509_52636} {RNA1509_11621, RNA1509_52636, RNA815_6109} |
23. | MligTC455_31487 | 6 | 0.11 | Mlig455_044778, Mlig455_053677 | Neo: - Age: - |
LMNTD1 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_044778 {REF} {Length: 2198} {TRANSSPLICED} {Pfam: 2OG-Fe(II) oxygenase superfamily [PF13532.8, score=51.2]; Intermediate filament protein [PF00038.23, score=25.1]} {Smed: dd_Smed_v6_10248_0_2, dd_Smed_v6_10248_0_2, [Score=108, Expect=4e-24]} {RNA1509_55106} {RNA1310_3989.1} {RNA815_1147.1} Mlig455_053677 {REF} {Length: 607} {Pfam: Intermediate filament protein [PF00038.23, score=52.8]; Lamin Tail Domain [PF00932.21, score=40.5]} {Human: ENSG00000152936, LMNTD1, lamin tail domain containing 1, [RH, Score=147, Expect=1e-37]} {Mouse: ENSMUSG00000054966, Lmntd1, lamin tail domain containing 1, [RH, Score=142, Expect=7e-36]} {Dmel: FBgn0002525, Lam, Lamin, [Score=72.8, Expect=9e-13]} {Celegans: WBGene00002051, ifa-3, Intermediate filament protein ifa-3, [Score=62.4, Expect=9e-10]} {Smed: dd_Smed_v6_10248_0_1, dd_Smed_v6_10248_0_1, [RH, Score=228, Expect=1e-62]} {RNA1509_55106} {RNA1310_3989.1} {RNA815_1147.1} |
24. | MligTC455_31663 | 23 | 0.48 | Mlig455_013845 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_013845 {REF} {Length: 1056} {RNA1310_32319} {RNA815_18072} | |
25. | MligTC455_54065 | 14 | 0.29 | Mlig455_027917 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_027917 {REF} {Length: 834} {RNA1509_53588} {RNA1310_52278} {RNA815_41341} | |
26. | MligTC455_07918 | 5 | 0.11 | Mlig455_063553 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_063553 {REF} {Length: 1818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.4]} {Smed: dd_Smed_v6_13742_0_1, dd_Smed_v6_13742_0_1, [Score=51.2, Expect=2e-07]} | |
27. | MligTC455_27812 | 26 | 0.54 | Mlig455_028987 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_028987 {REF} {Length: 705} {RNA1509_8341} {RNA1310_1311.2} {RNA815_19414} | |
28. | MligTC455_29408 | 45 | 0.94 | Mlig455_038322 | Neo: - Age: - Region-enriched R2: 8.586/0.00762 |
MB | 0.965 | - | - | - | - | 0.965 | - | Mlig455_038322 {REF} {Length: 2059} {Pfam: Globin [PF00042.24, score=57.8]} {Human: ENSG00000198125, MB, myoglobin, [RH, Score=47.8, Expect=5e-07]} {Mouse: ENSMUSG00000018893, Mb, myoglobin, [RH, Score=45.4, Expect=2e-06]} {Celegans: WBGene00008996, glb-14, GLoBin related, [Score=51.6, Expect=4e-08]} {Smed: dd_Smed_v6_15997_0_1, dd_Smed_v6_15997_0_1, [RH, Score=63.5, Expect=1e-12]} {RNA1509_48898} {RNA1310_47695} {RNA815_7096.1} |
29. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
0.965 | - | - | - | - | 0.965 | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
30. | MligTC455_35945 | 130 | 2.71 | Mlig455_065474 | Neo: - Age: Up-Down-Up |
0.965 | - | - | - | - | 0.965 | - | Mlig455_065474 {REF} {Length: 1654} {RNA1310_22530} {RNA815_54411} | |
31. | MligTC455_05674 | 11 | 0.23 | Mlig455_049667 | Neo: - Age: Down-Up-Down |
0.964 | - | - | - | - | 0.964 | - | Mlig455_049667 {REF} {Length: 2090} {Pfam: F-box domain [PF00646.35, score=23.2]} {RNA1509_42617} {RNA1310_13047.2, RNA1509_42617} {RNA1509_42617, RNA815_9747} | |
32. | MligTC455_20291 | 10 | 0.22 | Mlig455_026002 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_026002 {REF} {Length: 615} {NoTransDecoderORF} {RNA1509_54283} {RNA1310_25259} {RNA815_33357} | |
33. | MligTC455_23075 | 18 | 0.37 | Mlig455_022399 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_022399 {REF} {Length: 2552} {TRANSSPLICED} {RNA1509_19884} {RNA1310_57713.1} {RNA815_31584} | |
34. | MligTC455_34012 | 32 | 0.66 | Mlig455_054630 | Neo: - Age: Down-Up-Down |
0.964 | - | - | - | - | 0.964 | - | Mlig455_054630 {REF} {Length: 1964} {TRANSSPLICED} {RNA1509_56561} {RNA1310_4540, RNA1509_56561} {RNA1509_56561, RNA815_24860} | |
35. | MligTC455_35290 | 14 | 0.29 | Mlig455_015751, Mlig455_049473 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_015751 {REF} {Length: 1661} {RNA1509_27214} {RNA1310_93069} {RNA815_21353} Mlig455_049473 {REF} {Length: 733} {RNA1310_93069} |
|
36. | MligTC455_39603 | 7 | 0.14 | Mlig455_042384, Mlig455_070784 | Neo: - Age: - |
RTL1 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_042384 {REF} {Length: 2656} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=70.9]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=57.4]; Integrase zinc binding domain [PF17921.3, score=27.0]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=24.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=92.0, Expect=3e-19]} {Smed: dd_Smed_v6_24988_0_1, dd_Smed_v6_24988_0_1, [Score=196, Expect=9e-60]} {RNA1310_33025.2} {RNA815_8935} Mlig455_070784 {REF} {Length: 2269} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=70.9]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=57.4]; Integrase zinc binding domain [PF17921.3, score=27.6]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=24.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=92.0, Expect=3e-19]} {Smed: dd_Smed_v6_24988_0_1, dd_Smed_v6_24988_0_1, [Score=196, Expect=1e-59]} {RNA1310_33025.2} {RNA815_8935} |
37. | MligTC455_44956 | 144 | 2.99 | Mlig455_061510 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_061510 {REF} {Length: 493} {Pfam: Pancreatic hormone peptide [PF00159.20, score=31.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.8, Expect=9e-09]} {RNA1509_17163} {RNA1310_66833.1} {RNA815_41767} | |
38. | MligTC455_14036 | 33 | 0.69 | Mlig455_059133 | Neo: - Age: - Region-enriched R2: 6.942/0.00135 |
GRIK2 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_059133 {REF} {Length: 360} {TRANSSPLICED} {Pfam: Ligand-gated ion channel [PF00060.28, score=91.4]; Receptor family ligand binding region [PF01094.30, score=55.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=50.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=31.2]; Iron-containing alcohol dehydrogenase [PF13685.8, score=21.6]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=167, Expect=5e-42]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=166, Expect=8e-42]} {Dmel: FBgn0038837, CG3822, [Score=171, Expect=1e-43]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=129, Expect=1e-30]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [RH, Score=273, Expect=6e-84]} |
39. | MligTC455_28635 | 8 | 0.17 | Mlig455_035617 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_035617 {REF} {Length: 2961} {RNA1509_30363} {RNA1310_550} {RNA815_11944} | |
40. | MligTC455_35572 | 171 | 3.57 | Mlig455_052756 | Neo: - Age: - |
GBA2 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_052756 {REF} {Length: 5456} {TRANSSPLICED} {Pfam: Glycosyl-hydrolase family 116, catalytic region [PF04685.15, score=406.6]; beta-glucosidase 2, glycosyl-hydrolase family 116 N-term [PF12215.10, score=265.2]} {Human: ENSG00000070610, GBA2, glucosylceramidase beta 2, [RH, Score=574, Expect=0.0]} {Mouse: ENSMUSG00000028467, Gba2, glucosidase beta 2, [RH, Score=568, Expect=0.0]} {Dmel: FBgn0028916, CG33090, [RH, Score=350, Expect=2e-106]} {Celegans: WBGene00013670, hpo-13, Non-lysosomal glucosylceramidase, [RH, Score=536, Expect=7e-177]} {Smed: dd_Smed_v6_9887_0_1, dd_Smed_v6_9887_0_1, [RH, Score=619, Expect=0.0]} {RNA1509_35078, RNA1509_51930, RNA1509_53283, RNA1509_55884, RNA1509_56084} {RNA1310_7114.1, RNA1509_35078, RNA1509_53283, RNA1509_55884, RNA1509_56084} {RNA1509_35078, RNA1509_53283, RNA1509_55884, RNA1509_56084, RNA815_2167.1} |
41. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
0.963 | - | - | - | - | 0.963 | - | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
42. | MligTC455_48999 | 22 | 0.45 | Mlig455_042576 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_042576 {REF} {Length: 1021} {NoTransDecoderORF} {RNA1310_122955} | |
43. | MligTC455_07794 | 45 | 0.95 | Mlig455_028377, Mlig455_028380, Mlig455_068839 | Neo: Irradiation Age: Up-Down-Down |
0.962 | - | - | - | - | 0.962 | - | Mlig455_028377 {REF} {Length: 1201} {TRANSSPLICED} {Smed: dd_Smed_v6_14508_0_1, dd_Smed_v6_14508_0_1, [Score=65.5, Expect=3e-12]} {RNA1509_19070} {RNA1310_26251} {RNA815_28987} Mlig455_028380 {REF} {Length: 1062} {NoTransDecoderORF} {RNA1509_19070} {RNA1310_32802} {RNA815_15839} Mlig455_068839 {REF} {Length: 1819} {Smed: dd_Smed_v6_14508_0_1, dd_Smed_v6_14508_0_1, [Score=68.9, Expect=1e-13]} {RNA1509_19070} {RNA1310_34363} {RNA815_15839} |
|
44. | MligTC455_17052 | 6 | 0.13 | Mlig455_042555 | Neo: - Age: - |
GRIK2 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_042555 {REF} {Length: 2668} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=48.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=30.5]; Receptor family ligand binding region [PF01094.30, score=24.9]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=126, Expect=3e-29]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=126, Expect=3e-29]} {Dmel: FBgn0038837, CG3822, [Score=130, Expect=6e-31]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=108, Expect=5e-24]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=241, Expect=7e-72]} {RNA1310_33224} {RNA815_17044} |
45. | MligTC455_37326 | 22 | 0.46 | Mlig455_059334 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_059334 {REF} {Length: 312} {NoTransDecoderORF} {RNA1509_20376} {RNA1310_43662} {RNA815_4890} | |
46. | MligTC455_40000 | 13 | 0.27 | Mlig455_015867 | Neo: Irradiation Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_015867 {REF} {Length: 1292} {NoTransDecoderORF} {RNA1509_7266} {RNA1310_4601} {RNA815_30121} | |
47. | MligTC455_53769 | 8 | 0.16 | Mlig455_029802 | Neo: - Age: - |
EML1 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_029802 {REF} {Length: 3545} {TRANSSPLICED} {Pfam: HELP motif [PF03451.16, score=55.7]; WD domain, G-beta repeat [PF00400.34, score=46.4]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=39.7]; Family of unknown function (DUF5580) [PF17743.3, score=38.5]} {Human: ENSG00000066629, EML1, echinoderm microtubule associated protein like 1, [Score=162, Expect=4e-40]; ENSG00000125746, EML2, echinoderm microtubule associated protein like 2, [Score=158, Expect=5e-39]} {Mouse: ENSMUSG00000058070, Eml1, echinoderm microtubule associated protein like 1, [Score=163, Expect=8e-41]; ENSMUSG00000040811, Eml2, echinoderm microtubule associated protein like 2, [Score=161, Expect=5e-40]} {Dmel: FBgn0259099, DCX-EMAP, Doublecortin-domain-containing echinoderm-microtubule-associated protein, [Score=146, Expect=3e-35]} {Celegans: WBGene00001248, elp-1, Echinoderm microtubule-associated protein-like elp-1, [Score=107, Expect=3e-23]} {Smed: dd_Smed_v6_14226_0_1, dd_Smed_v6_14226_0_1, [Score=227, Expect=6e-61]} {RNA1310_73998} {RNA815_35585} |
48. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
49. | MligTC455_16052 | 21 | 0.45 | Mlig455_040149 | Neo: - Age: - |
TBX5 | 0.961 | - | - | - | - | 0.961 | - | Mlig455_040149 {REF} {Length: 1972} {Pfam: T-box [PF00907.24, score=232.7]} {Human: ENSG00000089225, TBX5, T-box 5, [Score=225, Expect=2e-67]; ENSG00000121075, TBX4, T-box 4, [Score=223, Expect=3e-66]; ENSG00000149922, TBX6, T-box 6, [Score=220, Expect=3e-66]; ENSG00000121068, TBX2, T-box 2, [Score=218, Expect=3e-63]; ENSG00000135111, TBX3, T-box 3, [Score=214, Expect=2e-61]} {Mouse: ENSMUSG00000018263, Tbx5, T-box 5, [Score=225, Expect=2e-67]; ENSMUSG00000000094, Tbx4, T-box 4, [Score=224, Expect=1e-66]; ENSMUSG00000030699, Tbx6, T-box 6, [Score=221, Expect=1e-66]; ENSMUSG00000018604, Tbx3, T-box 3, [Score=219, Expect=1e-63]; ENSMUSG00000000093, Tbx2, T-box 2, [Score=218, Expect=4e-63]} {Dmel: FBgn0028789, Doc1, Dorsocross1, [Score=239, Expect=3e-74]} {Celegans: WBGene00003376, mls-1, T-box transcription factor mls-1, [Score=199, Expect=5e-61]} {Smed: dd_Smed_v6_11693_0_1, dd_Smed_v6_11693_0_1, [Score=220, Expect=5e-65]} {RNA1310_67229} |
50. | MligTC455_24844 | 70 | 1.45 | Mlig455_016641, Mlig455_035592 | Neo: - Age: - Region-enriched R4: 2.424/0.04540 |
0.961 | - | - | - | - | 0.961 | - | Mlig455_016641 {REF} {Length: 2405} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=70.0]} {Smed: dd_Smed_v6_14020_0_1, dd_Smed_v6_14020_0_1, [RH, Score=145, Expect=5e-44]} {RNA1509_2024} {RNA1310_10624} {RNA815_8671} Mlig455_035592 {REF} {Length: 632} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=70.0]} {Smed: dd_Smed_v6_14020_0_1, dd_Smed_v6_14020_0_1, [RH, Score=145, Expect=5e-44]} {RNA1310_10624} {RNA815_27265} |
|
51. | MligTC455_42457 | 63 | 1.31 | Mlig455_020182 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-0.680 Region-enriched R4: 3.390/0.03030 |
0.961 | - | - | - | - | 0.961 | - | Mlig455_020182 {REF} {Length: 1595} {TRANSSPLICED} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=57.0, Expect=2e-10]} {RNA1509_59965} {RNA1310_27831} {RNA815_27307} | |
52. | MligTC455_50602 | 84 | 1.74 | Mlig455_065088 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_065088 {REF} {Length: 2765} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=129.5]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=67.8, Expect=6e-12]} {RNA1310_8235} {RNA815_10456.1} | |
53. | MligTC455_11559 | 259 | 5.4 | Mlig455_058274, Mlig455_070792 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.973 Region-enriched R2: 6.488/0.00000 |
0.96 | - | - | - | - | 0.960 | - | Mlig455_058274 {REF} {Length: 786} {RNA1509_58923} {RNA1310_41706} {RNA815_20876} Mlig455_070792 {REF} {Length: 891} {RNA1509_58923} {RNA1310_41706} {RNA815_20876} |
|
54. | MligTC455_12514 | 30 | 0.63 | Mlig455_037415 | Neo: - Age: - |
CHRNA6 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_037415 {REF} {Length: 1606} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=77.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=77.4, Expect=4e-16]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=75.1, Expect=2e-15]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=73.9, Expect=7e-15]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=80.5, Expect=3e-17]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=84.7, Expect=7e-19]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=72.8, Expect=5e-15]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=82.0, Expect=3e-18]} {RNA1509_53098} {RNA1310_110770} {RNA815_49679} |
55. | MligTC455_28711 | 44 | 0.91 | Mlig455_022368, Mlig455_022378, Mlig455_022455 | Neo: - Age: - |
KREMEN2 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_022368 {REF} {Length: 1557} {Pfam: WSC domain [PF01822.21, score=45.5]; PAN domain [PF00024.28, score=22.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=46.2, Expect=1e-05]} {RNA1310_35396.1} {RNA815_23500} Mlig455_022378 {REF} {Length: 1444} {Pfam: WSC domain [PF01822.21, score=37.3]; PAN domain [PF00024.28, score=21.3]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.1, Expect=1e-05]} {RNA1310_89673} {RNA815_59435} Mlig455_022455 {REF} {Length: 1345} {Pfam: WSC domain [PF01822.21, score=51.4]; PAN domain [PF00024.28, score=23.1]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=7e-07]} {RNA1310_89673} {RNA815_23500} |
56. | MligTC455_36012 | 18 | 0.38 | Mlig455_002402, Mlig455_057634 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_002402 {REF} {Length: 1022} {RNA1509_35444} {RNA1310_65842} {RNA815_52332} Mlig455_057634 {REF} {Length: 2686} {RNA1509_18844} {RNA1310_65842} {RNA815_52332} |
|
57. | MligTC455_41723 | 46 | 0.97 | Mlig455_001714 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_001714 {REF} {Length: 1881} {RNA1310_22665} {RNA815_13308} | |
58. | MligTC455_45811 | 216 | 4.5 | Mlig455_015628 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.807/0.00004 |
0.96 | - | - | - | - | 0.960 | - | Mlig455_015628 {REF} {Length: 1061} {RNA1310_43338} {RNA815_24238} | |
59. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
0.96 | - | - | - | - | 0.960 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
60. | MligTC455_51386 | 763 | 15.89 | Mlig455_041336, Mlig455_056222 | Neo: - Age: - Region-enriched R2: 3.643/0.00016 |
HPGDS | 0.96 | - | - | - | - | 0.960 | - | Mlig455_041336 {REF} {Length: 1363} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=46.9]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.3]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.4]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=74.7, Expect=2e-15]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00001756, gst-8, Probable glutathione S-transferase 8, [Score=92.8, Expect=2e-22]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=79.0, Expect=2e-17]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} Mlig455_056222 {REF} {Length: 1343} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=62.1]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, C-terminal domain [PF00043.27, score=31.1]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.4]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.5]; Glutathione S-transferase, C-terminal domain [PF13410.8, score=21.8]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=78.2, Expect=8e-17]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=85.5, Expect=1e-19]} {Celegans: WBGene00001750, gst-2, Glutathione S-transferase 2, [RH, Score=96.7, Expect=3e-24]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=84.3, Expect=2e-19]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} |
61. | MligTC455_09595 | 48 | 1.01 | Mlig455_030009 | Neo: - Age: - |
OPRM1 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_030009 {REF} {Length: 1508} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=44.4]; Serpentine type 7TM GPCR chemoreceptor Sra [PF02117.18, score=19.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=19.6]} {Human: ENSG00000112038, OPRM1, opioid receptor mu 1, [Score=56.2, Expect=5e-08]} {Mouse: ENSMUSG00000000766, Oprm1, opioid receptor, mu 1, [Score=54.7, Expect=9e-08]} {Celegans: WBGene00021510, frpr-19, FMRFamide Peptide Receptor family, [Score=47.8, Expect=7e-06]} {RNA1310_43388} {RNA815_47203} |
62. | MligTC455_26397 | 4 | 0.08 | Mlig455_055594 | Neo: - Age: - |
GABBR2 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_055594 {REF} {Length: 6313} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=206.3]; Receptor family ligand binding region [PF01094.30, score=127.7]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [RH, Score=430, Expect=7e-134]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [RH, Score=418, Expect=1e-129]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [RH, Score=478, Expect=3e-149]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [RH, Score=377, Expect=1e-115]} {Smed: dd_Smed_v6_59890_0_1, dd_Smed_v6_59890_0_1, [RH, Score=192, Expect=2e-56]} {RNA1509_48347} {RNA1310_32713, RNA1509_48347} {RNA1509_48347, RNA815_19840} |
63. | MligTC455_29482 | 49 | 1.03 | Mlig455_016797 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_016797 {REF} {Length: 3680} {RNA1509_4722} {RNA1310_655.4} {RNA815_335.1} | |
64. | MligTC455_31901 | 18 | 0.38 | Mlig455_022355 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_022355 {REF} {Length: 541} {Pfam: PAN domain [PF00024.28, score=19.0]} {RNA1310_125793} {RNA815_23776.1} | |
65. | MligTC455_51095 | 19 | 0.4 | Mlig455_048603 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_048603 {REF} {Length: 867} {NoTransDecoderORF} {RNA1509_36707} {RNA1310_125978} {RNA815_41194.1} | |
66. | MligTC455_53594 | 55 | 1.15 | Mlig455_028296, Mlig455_069567 | Neo: - Age: Down-Up-Down |
SLC24A2 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_028296 {REF} {Length: 4685} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=158.5]} {Human: ENSG00000155886, SLC24A2, solute carrier family 24 member 2, [Score=453, Expect=4e-151]} {Mouse: ENSMUSG00000037996, Slc24a2, solute carrier family 24 (sodium/potassium/calcium exchanger), member 2, [Score=453, Expect=9e-151]} {Dmel: FBgn0028704, Nckx30C, [Score=460, Expect=2e-151]} {Celegans: WBGene00003569, ncx-4, Na/Ca eXchangers, [Score=222, Expect=5e-64]} {Smed: dd_Smed_v6_5868_0_4, dd_Smed_v6_5868_0_4, [Score=186, Expect=2e-51]} {RNA1509_26587} {RNA1310_76563} {RNA815_21902.1} Mlig455_069567 {REF} {Length: 4230} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=186.7]} {Human: ENSG00000155886, SLC24A2, solute carrier family 24 member 2, [RH, Score=496, Expect=1e-167]} {Mouse: ENSMUSG00000037996, Slc24a2, solute carrier family 24 (sodium/potassium/calcium exchanger), member 2, [RH, Score=501, Expect=4e-169]} {Dmel: FBgn0028704, Nckx30C, [RH, Score=501, Expect=3e-167]} {Celegans: WBGene00003569, ncx-4, Na/Ca eXchangers, [Score=226, Expect=4e-65]} {Smed: dd_Smed_v6_5868_0_4, dd_Smed_v6_5868_0_4, [Score=186, Expect=2e-51]} {RNA1509_26587} {RNA1310_76563} {RNA815_21902.1} |
67. | MligTC455_00067 | 6 | 0.13 | Mlig455_035302 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_035302 {REF} {Length: 1437} | |
68. | MligTC455_00401 | 18 | 0.37 | Mlig455_066572 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_066572 {REF} {Length: 123} {NoTransDecoderORF} {RNA1310_85631} | |
69. | MligTC455_04385 | 2 | 0.05 | Mlig455_036481 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_036481 {REF} {Length: 437} {NoTransDecoderORF} | |
70. | MligTC455_11746 | 10 | 0.21 | Mlig455_050886 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_050886 {REF} {Length: 2262} {Pfam: Cryptococcal mannosyltransferase 1 [PF11735.10, score=23.8]} {RNA1509_16212} {RNA1310_23116} {RNA815_8985.1} | |
71. | MligTC455_13070 | 8 | 0.17 | Mlig455_052214 | Neo: - Age: - |
CHRNA9 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_052214 {REF} {Length: 1717} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=61.0]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=72.4, Expect=3e-14]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=70.5, Expect=8e-14]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=57.8, Expect=1e-09]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=62.8, Expect=2e-11]} {Smed: dd_Smed_v6_24739_0_1, dd_Smed_v6_24739_0_1, [Score=63.5, Expect=9e-12]} {RNA1509_45927} {RNA1310_64664.1} {RNA815_37999} |
72. | MligTC455_14872 | 28 | 0.58 | Mlig455_064004, Mlig455_064044 | Neo: - Age: logFC(26M/2M)=1.526 |
CLCA1 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_064004 {REF} {Length: 4380} {Pfam: von Willebrand factor type A domain [PF00092.30, score=55.0]; von Willebrand factor type A domain [PF13768.8, score=48.2]; von Willebrand factor type A domain [PF13519.8, score=47.8]; vWA found in TerF C terminus [PF10138.11, score=29.1]; VWA domain containing CoxE-like protein [PF05762.16, score=28.0]; Calcium-activated chloride channel N terminal [PF08434.13, score=19.9]} {Human: ENSG00000016490, CLCA1, chloride channel accessory 1, [Score=150, Expect=1e-36]} {Mouse: ENSMUSG00000028255, Clca1, chloride channel accessory 1, [Score=154, Expect=6e-38]} {Smed: dd_Smed_v6_968_0_1, dd_Smed_v6_968_0_1, [Score=89.0, Expect=6e-18]} {RNA1509_43698} {RNA1310_4397} {RNA815_4081} Mlig455_064044 {REF} {Length: 4389} {Pfam: von Willebrand factor type A domain [PF00092.30, score=57.6]; von Willebrand factor type A domain [PF13768.8, score=50.7]; von Willebrand factor type A domain [PF13519.8, score=47.7]; vWA found in TerF C terminus [PF10138.11, score=29.0]; VWA domain containing CoxE-like protein [PF05762.16, score=26.0]; Calcium-activated chloride channel N terminal [PF08434.13, score=24.0]} {Human: ENSG00000016490, CLCA1, chloride channel accessory 1, [Score=157, Expect=9e-39]} {Mouse: ENSMUSG00000028255, Clca1, chloride channel accessory 1, [Score=159, Expect=2e-39]} {Smed: dd_Smed_v6_968_0_1, dd_Smed_v6_968_0_1, [Score=91.3, Expect=1e-18]} {RNA1509_43698} {RNA1310_4397, RNA1509_43698} {RNA1509_43698, RNA815_4081} |
73. | MligTC455_40178 | 24 | 0.51 | Mlig455_047702 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_047702 {REF} {Length: 1508} {RNA1310_82391} {RNA815_55957} | |
74. | MligTC455_43875 | 9 | 0.19 | Mlig455_069048 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_069048 {REF} {Length: 575} {NoTransDecoderORF} {RNA1310_139137} | |
75. | MligTC455_46155 | 116 | 2.42 | Mlig455_027239 | Neo: - Age: - Region-enriched R2: 4.163/0.03818 |
GRK3 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_027239 {REF} {Length: 2919} {Pfam: Protein kinase domain [PF00069.27, score=226.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=100.5]; Regulator of G protein signaling domain [PF00615.21, score=48.3]} {Human: ENSG00000100077, GRK3, G protein-coupled receptor kinase 3, [Score=845, Expect=0.0]; ENSG00000173020, GRK2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Mouse: ENSMUSG00000042249, Grk3, G protein-coupled receptor kinase 3, [Score=838, Expect=0.0]; ENSMUSG00000024858, Grk2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Dmel: FBgn0260798, Gprk1, G protein-coupled receptor kinase 1, [Score=842, Expect=0.0]} {Celegans: WBGene00001709, grk-2, G protein-coupled receptor kinase 2, [Score=819, Expect=0.0]} {Smed: dd_Smed_v6_6480_0_1, dd_Smed_v6_6480_0_1, [Score=949, Expect=0.0]} {RNA1509_7002} {RNA1310_16658} {RNA815_28070} |
76. | MligTC455_53103 | 10 | 0.22 | Mlig455_031283 | Neo: - Age: - |
PRKG1 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_031283 {REF} {Length: 3343} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=75.9]} {Human: ENSG00000185532, PRKG1, protein kinase cGMP-dependent 1, [Score=62.8, Expect=1e-09]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=63.5, Expect=6e-10]} {Dmel: FBgn0000721, for, foraging, [Score=60.1, Expect=5e-09]} {Celegans: WBGene00004255, epac-1, Rap guanine nucleotide exchange factor 1, [Score=57.0, Expect=3e-08]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=201, Expect=3e-56]} {RNA1509_48062} {RNA1310_17067.1} {RNA815_20554} |
77. | MligTC455_53869 | 27 | 0.57 | Mlig455_060247 | Neo: - Age: - |
CHDH | 0.958 | - | - | - | - | 0.958 | - | Mlig455_060247 {REF} {Length: 2837} {Pfam: GMC oxidoreductase [PF00732.21, score=82.3]; GMC oxidoreductase [PF05199.15, score=61.5]; FAD dependent oxidoreductase [PF01266.26, score=20.3]; Lycopene cyclase protein [PF05834.14, score=18.0]} {Human: ENSG00000016391, CHDH, choline dehydrogenase, [Score=101, Expect=6e-22]} {Mouse: ENSMUSG00000015970, Chdh, choline dehydrogenase, [Score=103, Expect=9e-23]} {Dmel: FBgn0037896, ninaG, [Score=116, Expect=3e-27]} {Celegans: WBGene00007917, C34C6.4, [Score=65.9, Expect=4e-11]} {Smed: dd_Smed_v6_13047_0_2, dd_Smed_v6_13047_0_2, [RH, Score=166, Expect=2e-44]} {RNA1310_47881.1} |
78. | MligTC455_14408 | 25 | 0.51 | Mlig455_065855, Mlig455_065862 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_065855 {REF} {Length: 505} {NoTransDecoderORF} {RNA1310_1284} {RNA815_45080} Mlig455_065862 {REF} {Length: 687} {NoTransDecoderORF} {RNA1310_1284} {RNA815_45080} |
|
79. | MligTC455_14842 | 21 | 0.45 | Mlig455_041074 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_041074 {REF} {Length: 1383} {RNA1310_60383} {RNA815_48502} | |
80. | MligTC455_17321 | 10 | 0.21 | Mlig455_056084 | Neo: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_056084 {REF} {Length: 3976} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=25.9]; Ankyrin repeats (many copies) [PF13857.8, score=25.5]; Ankyrin repeat [PF00023.32, score=25.3]; Ankyrin repeat [PF13606.8, score=22.5]; Ankyrin repeats (many copies) [PF13637.8, score=20.0]} {Smed: dd_Smed_v6_8547_0_1, dd_Smed_v6_8547_0_1, [Score=54.3, Expect=4e-07]} {RNA1509_34786} {RNA1310_3679.2, RNA1509_34786} {RNA1509_34786, RNA815_15539} | |
81. | MligTC455_20292 | 24 | 0.5 | Mlig455_050686 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_050686 {REF} {Length: 990} {NoTransDecoderORF} {RNA1509_54283} {RNA1310_25259, RNA1509_54283} {RNA1509_54283, RNA815_33357} | |
82. | MligTC455_26356 | 62 | 1.3 | Mlig455_042551 | Neo: - |
GRIK2 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_042551 {REF} {Length: 2917} {Pfam: Ligand-gated ion channel [PF00060.28, score=82.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=60.7]; Receptor family ligand binding region [PF01094.30, score=32.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=27.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=144, Expect=9e-35]; ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=141, Expect=7e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=143, Expect=1e-34]; ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=142, Expect=2e-34]} {Dmel: FBgn0051201, GluRIIE, Glutamate receptor IIE, [Score=119, Expect=3e-27]} {Celegans: WBGene00001616, glr-5, GLutamate Receptor family (AMPA), [Score=123, Expect=2e-28]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=247, Expect=4e-74]} {RNA1310_21865} {RNA815_26044} |
83. | MligTC455_31163 | 72 | 1.51 | Mlig455_045625 | Neo: - Age: Up-Down-Down |
0.957 | - | - | - | - | 0.957 | - | Mlig455_045625 {REF} {Length: 1957} {RNA1509_21720} {RNA1310_14760, RNA1509_21720} {RNA1509_21720, RNA815_24583} | |
84. | MligTC455_33939 | 15 | 0.31 | Mlig455_018477 | Neo: Int S/G2/M |
GUCY1B1 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_018477 {REF} {Length: 4178} {Pfam: Heme NO binding associated [PF07701.16, score=239.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=198.0]; Haem-NO-binding [PF07700.17, score=172.7]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=343, Expect=9e-106]} {Mouse: ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=350, Expect=4e-106]; ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=348, Expect=7e-108]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=622, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=530, Expect=2e-176]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=818, Expect=0.0]} {RNA1509_41885} {RNA1310_21359} {RNA815_6599.2} |
85. | MligTC455_10281 | 4 | 0.07 | Mlig455_014171 | Neo: - Age: - |
HERC4 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_014171 {REF} {Length: 2849} {TRANSSPLICED} {tRNA: Thr(AGT), score=78.7} {Pfam: Regulator of chromosome condensation (RCC1) repeat [PF00415.20, score=207.5]; Regulator of chromosome condensation (RCC1) repeat [PF13540.8, score=145.9]} {Human: ENSG00000148634, HERC4, HECT and RLD domain containing E3 ubiquitin protein ligase 4, [RH, Score=423, Expect=7e-134]} {Mouse: ENSMUSG00000020064, Herc4, hect domain and RLD 4, [Score=422, Expect=4e-133]} {Dmel: FBgn0035207, Sherpa, SUMO-related HECT domain and RCC repeat protein for Toll pathway activation, [Score=413, Expect=2e-129]} {Celegans: WBGene00021685, herc-1, HECT and RCC domain E3 ubiquitin ligase, [Score=265, Expect=1e-75]} {Smed: dd_Smed_v6_8701_0_1, dd_Smed_v6_8701_0_1, [Score=362, Expect=8e-111]} {RNA1509_7831} {RNA1310_2988.2} {RNA815_973} |
86. | MligTC455_10953 | 148 | 3.08 | Mlig455_060864, Mlig455_063528 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.497/0.01237 |
KCNH7 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_060864 {REF} {Length: 7144} {Pfam: Ion transport protein [PF00520.33, score=117.5]; Cyclic nucleotide-binding domain [PF00027.31, score=52.7]; Ion channel [PF07885.18, score=45.4]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=777, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=760, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=751, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=776, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=761, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=751, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=741, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=712, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=798, Expect=0.0]} {RNA1509_40124} {RNA1310_4074} {RNA815_8044} Mlig455_063528 {REF} {Length: 734} {NoTransDecoderORF} |
87. | MligTC455_14483 | 140 | 2.92 | Mlig455_028240 | Neo: - Age: - Region-enriched R2: 6.203/0.04837 |
0.956 | - | - | - | - | 0.956 | - | Mlig455_028240 {REF} {Length: 728} {RNA1310_111517} {RNA815_9716} | |
88. | MligTC455_15822 | 18 | 0.38 | Mlig455_024112, Mlig455_024114 | Neo: - Age: logFC(26M/2M)=-0.529 |
SV2C | 0.956 | - | - | - | - | 0.956 | - | Mlig455_024112 {REF} {Length: 2710} {Pfam: Major Facilitator Superfamily [PF07690.18, score=114.0]; Sugar (and other) transporter [PF00083.26, score=89.6]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=22.6]} {Human: ENSG00000122012, SV2C, synaptic vesicle glycoprotein 2C, [Score=167, Expect=1e-43]; ENSG00000185518, SV2B, synaptic vesicle glycoprotein 2B, [Score=164, Expect=1e-43]} {Mouse: ENSMUSG00000053025, Sv2b, synaptic vesicle glycoprotein 2 b, [Score=184, Expect=5e-50]} {Dmel: FBgn0029896, CG3168, [Score=193, Expect=1e-53]} {Celegans: WBGene00013318, Y57G11C.23, [Score=49.3, Expect=5e-06]} {Smed: dd_Smed_v6_35070_0_1, dd_Smed_v6_35070_0_1, [Score=83.6, Expect=6e-17]} {RNA1310_46505} {RNA815_39243} Mlig455_024114 {REF} {Length: 2664} {Pfam: Major Facilitator Superfamily [PF07690.18, score=116.1]; Sugar (and other) transporter [PF00083.26, score=90.9]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=22.6]} {Human: ENSG00000122012, SV2C, synaptic vesicle glycoprotein 2C, [Score=169, Expect=4e-44]; ENSG00000185518, SV2B, synaptic vesicle glycoprotein 2B, [Score=167, Expect=9e-45]} {Mouse: ENSMUSG00000053025, Sv2b, synaptic vesicle glycoprotein 2 b, [Score=187, Expect=3e-51]} {Dmel: FBgn0029896, CG3168, [Score=195, Expect=3e-54]} {Celegans: WBGene00013318, Y57G11C.23, [Score=49.3, Expect=5e-06]} {Smed: dd_Smed_v6_35070_0_1, dd_Smed_v6_35070_0_1, [Score=84.0, Expect=5e-17]} {RNA1310_46505} {RNA815_39243} |
89. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
90. | MligTC455_50778 | 36 | 0.76 | Mlig455_042296 | Neo: - Age: - |
GPR50 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_042296 {REF} {Length: 1415} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=40.0]; Olfactory receptor [PF13853.8, score=34.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=33.9]} {Human: ENSG00000102195, GPR50, G protein-coupled receptor 50, [Score=124, Expect=4e-31]; ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=119, Expect=2e-30]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=120, Expect=4e-31]; ENSMUSG00000056380, Gpr50, G-protein-coupled receptor 50, [Score=119, Expect=2e-29]; ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=118, Expect=5e-30]} {Dmel: FBgn0038980, Octbeta1R, Octopamine beta1 receptor, [Score=92.0, Expect=1e-20]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=69.7, Expect=4e-13]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=84.7, Expect=1e-18]} {RNA1310_66047} {RNA815_34066} |
91. | MligTC455_07614 | 39 | 0.81 | Mlig455_022829, Mlig455_022910, Mlig455_022919 | Neo: - Age: Up-Down-Down |
0.955 | - | - | - | - | 0.955 | - | Mlig455_022829 {REF} {Length: 304} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_46811} {RNA1310_886.2} {RNA815_1557} Mlig455_022910 {REF} {Length: 230} {NoTransDecoderORF} {RNA1509_46811} {RNA1310_886.2} {RNA815_1557} Mlig455_022919 {REF} {Length: 318} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_46811} {RNA1310_886.2} {RNA815_1557} |
|
92. | MligTC455_12446 | 8 | 0.17 | Mlig455_018624, Mlig455_018810 | Neo: - Age: - |
CHRNA10, CHRNA7 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_018624 {REF} {Length: 3606} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=112.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=72.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=143, Expect=2e-35]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=142, Expect=2e-35]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=1e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=1e-34]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=136, Expect=2e-33]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=145, Expect=2e-36]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=141, Expect=3e-35]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=140, Expect=2e-35]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=139, Expect=2e-34]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=142, Expect=2e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=3e-36]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=138, Expect=2e-34]} {RNA1509_9118} {RNA1310_65904} {RNA815_40596} Mlig455_018810 {REF} {Length: 2717} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=112.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=72.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=141, Expect=2e-35]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=2e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=139, Expect=2e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=139, Expect=2e-34]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=138, Expect=4e-34]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=145, Expect=2e-36]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=141, Expect=2e-35]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=140, Expect=8e-35]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=7e-35]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=142, Expect=1e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=4e-36]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=139, Expect=1e-34]} {RNA1509_9118} {RNA1310_84333} {RNA815_40596} |
93. | MligTC455_14843 | 19 | 0.39 | Mlig455_064713 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_064713 {REF} {Length: 1584} {RNA1310_60383} {RNA815_48502} | |
94. | MligTC455_20953 | 115 | 2.4 | Mlig455_002904 | Neo: - Age: - Region-enriched R2: 5.041/0.00953 |
0.955 | - | - | - | - | 0.955 | - | Mlig455_002904 {REF} {Length: 1514} {RNA1310_19276} {RNA815_20827} | |
95. | MligTC455_23040 | 94 | 1.97 | Mlig455_023257, Mlig455_034104, Mlig455_034113 | Neo: Irradiation Age: Up-Down-Up |
PKDREJ | 0.955 | - | - | - | - | 0.955 | - | Mlig455_023257 {REF} {Length: 2691} {Pfam: Lectin C-type domain [PF00059.23, score=32.0]} {RNA1509_11123} {RNA1310_3227.1} {RNA815_39190} Mlig455_034104 {REF} {Length: 3178} {Pfam: Lectin C-type domain [PF00059.23, score=30.4]} {RNA1509_11123} {RNA1310_3227.1} {RNA815_27867} Mlig455_034113 {REF} {Length: 15969} {Pfam: Polycystin cation channel [PF08016.14, score=152.5]; Lectin C-type domain [PF00059.23, score=62.0]; F5/8 type C domain [PF00754.27, score=59.0]; Ion transport protein [PF00520.33, score=32.5]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=105, Expect=3e-21]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=102, Expect=2e-20]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=149, Expect=8e-35]} {Dmel: FBgn0040333, brv3, brivido-3, [Score=57.8, Expect=3e-07]} {Smed: dd_Smed_v6_10962_0_1, dd_Smed_v6_10962_0_1, [Score=130, Expect=2e-29]} {RNA1509_11123} {RNA1310_8659} {RNA815_2535} |
96. | MligTC455_23543 | 79 | 1.65 | Mlig455_021851 | Neo: - Age: - Region-enriched R2: 5.153/0.00077 |
MAP3K19 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_021851 {REF} {Length: 7454} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=226.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=217.3]; Ankyrin repeats (3 copies) [PF12796.9, score=113.8]; Ankyrin repeats (many copies) [PF13637.8, score=82.7]; Ankyrin repeats (many copies) [PF13857.8, score=77.3]; F5/8 type C domain [PF00754.27, score=56.3]; Ankyrin repeat [PF00023.32, score=55.9]; Ankyrin repeat [PF13606.8, score=49.9]; ABC1 atypical kinase-like domain [PF03109.18, score=28.7]} {Human: ENSG00000176601, MAP3K19, mitogen-activated protein kinase kinase kinase 19, [Score=159, Expect=2e-40]} {Mouse: ENSMUSG00000051590, Map3k19, mitogen-activated protein kinase kinase kinase 19, [Score=164, Expect=3e-42]} {Dmel: FBgn0266465, GckIII, Germinal centre kinase III, [Score=146, Expect=1e-35]} {Celegans: WBGene00001526, gck-1, Germinal center kinase 1, [Score=139, Expect=2e-33]} {Smed: dd_Smed_v6_10339_0_1, dd_Smed_v6_10339_0_1, [Score=153, Expect=2e-37]} {RNA1509_46581} {RNA1310_9191} {RNA815_12161} |
97. | MligTC455_40290 | 58 | 1.21 | Mlig455_058728 | Neo: - Age: - Region-enriched R2: 4.464/0.00807 |
0.955 | - | - | - | - | 0.955 | - | Mlig455_058728 {REF} {Length: 1351} {Pfam: CUB domain [PF00431.22, score=48.4]} {RNA1310_48745} {RNA815_23305} | |
98. | MligTC455_41130 | 1186 | 24.72 | Mlig455_000166, Mlig455_000179, Mlig455_067712 | Neo: - Age: Down-Up-Down Region-specific R2: 5.626 Region-enriched R2: 4.906/0.00009 Regeneration-downregulated R3: -5.200 Regeneration-depleted R3: -5.200 |
0.955 | - | - | - | - | 0.955 | - | Mlig455_000166 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_000179 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_067712 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} |
|
99. | MligTC455_45487 | 110 | 2.3 | Mlig455_004129, Mlig455_060457 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_004129 {REF} {Length: 1131} {Pfam: PAN domain [PF00024.28, score=18.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=64.3, Expect=2e-12]} {RNA1310_37660} {RNA815_17816.1} Mlig455_060457 {REF} {Length: 1507} {Pfam: PAN domain [PF00024.28, score=19.5]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=64.3, Expect=2e-12]} {RNA1509_54623} {RNA1310_33480} {RNA815_17816.1} |
|
100. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 0.955 | - | - | - | - | 0.955 | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |